Zilver® PTX® Drug-Eluting Peripheral Stent From Cook Medical Qualifies for Additional Medicare Reimbursement

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BLOOMINGTON, Ind.--(BUSINESS WIRE)--Effective October 1, Cook Medical’s Zilver® PTX® Drug-Eluting Peripheral Stent qualifies for new-technology add-on payments under Medicare’s hospital inpatient prospective payment system.

Help employers find you! Check out all the jobs and post your resume.

Back to news